Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -96.44%. However, over the last six months, the performance has been stronger by -96.75%. The price of FGEN decreased -1.04% over the last 30 days. And in the last five days, it has surged by 50.09%.
FibroGen Inc (FGEN) current stock price is $0.57. During the last trading session, the stock soared, reaching $0.575 after opening at $0.5119. The stock’s lowest point was $0.50 before it closed at $0.50.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
FibroGen Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $25.69 on 02/03/23, while the lowest price during the same period was $0.33 on 11/10/23.
52-week price history of FGEN Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. FibroGen Inc’s current trading price is -97.78% away from its 52-week high, while its distance from the 52-week low is 71.17%. The stock’s price range over this timeframe has been between $0.33 and $25.69. The shares of the Healthcare sector company recorded a trading volume of approximately 1.71 million for the day, which was comparatively lower than the average daily volume of 4.12 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
FibroGen Inc (FGEN) has experienced a quarterly decline of -54.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 56.10M and boasts a workforce of 592 employees.
Expert Opinions: Analysts’ Ratings for FibroGen Inc
As of right now, 0 analyst is rating FibroGen Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2470, with a change in price of -1.9195. Similarly, FibroGen Inc recorded 3,826,813 in trading volume during the last 100 days, posting a change of -77.09%.
FGEN Stock Stochastic Average
FibroGen Inc’s raw stochastic average for the past 50 days is currently at 30.54%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 62.97%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 51.44% and 43.65%, respectively.
